Monoclonal Mouse anti‑Human GTF2A1L / ALF Antibody (clone OTI1D3, Carrier‑free, aa183‑478, WB) LS‑C792614
Monoclonal Mouse anti‑Human GTF2A1L / ALF Antibody (clone OTI1D3, Carrier‑free, aa183‑478, WB) LS‑C792614
Antibody:
GTF2A1L / ALF Mouse anti-Human Monoclonal (aa183-478) (Carrier-free) (OTI1D3) Antibody
Format:
Unconjugated, Carrier-free
Overview
Antibody:
GTF2A1L / ALF Mouse anti-Human Monoclonal (aa183-478) (Carrier-free) (OTI1D3) Antibody
Format:
Unconjugated, Carrier-free
Specifications
Description
ALF antibody LS-C792614 is an unconjugated mouse monoclonal antibody to human ALF (GTF2A1L) (aa183-478). Validated for WB.
Target
Human GTF2A1L / ALF
Synonyms
GTF2A1L | ALF | GTF2A1-like factor | GTF2A1LF | TFIIA-alpha/beta-like factor
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG2b
Monoclonal
Conjugations
Unconjugated
Purification
Affinity chromatography
Modifications
Carrier-free.
Also available
Unmodified.
Immunogen
Human recombinant protein fragment corresponding to amino acids 183-478 of human GTF2A1L (NP_006863) produced in E.coli.
Applications
- Western blot (1:500 - 1:2000)
Usage
Applications should be user optimized.
Presentation
PBS, pH 7.3, 8% Trehalose
Reconstitution
Reconstitute with PBS pH 7.3. To use this carrier-free antibody for conjugation experiment, we strongly recommend you to perform another round of desalting process.
Storage
Store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human, Rat
Applications:
Western blot, ELISA
Species:
Human
Applications:
Western blot, ELISA
Species:
Human
Applications:
Western blot, ELISA
Species:
Human, Rat
Applications:
Western blot, ELISA
Source:
Wheat
Tag:
GST, N-terminus
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 4/27/2024